Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Assistance

NCT: NCT06496958 · RECRUITING

NCT IDNCT06496958
StatusRECRUITING
Start Date2024-09-02
Completion2026-12-31
SponsorEvergreen General Hospital, Taiwan (OTHER)
First posted
Last updated

Brief Summary

The goal of this trial is to evaluate whether water exchange colonoscopy and CO2-insufflation colonoscopy with an abdominal compression device (Maxbelt me3 type, Nippon Sigmax Co., Tokyo, Japan) can achieve a significantly lower proportion of patients requiring manual abdominal pressure during colonoscopic insertion compared with CO2 insufflation alone.

Frequently Asked Questions

What is Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Assistance?

Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Assistance is a clinical trial registered under NCT06496958. Current status: RECRUITING.

What is the status of NCT06496958?

The current status of NCT06496958 (Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Assistance) is: RECRUITING.

When did Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Assistance start?

Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Assistance started on 2024-09-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑